Page 49 - Climate Conference - EBook 2023: Al-Qasemi Academy

Medicine Development in the Light of the
Climate Change Crisis
Prof. Anwar Rayan

President of Al-Qasemi Academic College

Medicine Development in the Light of the Climate Change Crisis: Insights from the Fourth
Session of the International Conference at Al-Qasemi Academic College - 2023
Al-Qasemi Academy's International Conference on "Climate Crisis and its Coping
Strategies" continued its momentum on the fourth day (15/3/2023), featuring a diverse
range of sessions. Among them, a highly anticipated workshop titled "Medicine
Development in Light of the Climate Change Crisis" brought together esteemed academic
researchers and industry practitioners. The workshop delved into crucial discussions on
how to significantly contribute to the advancement of medicine development, enhance
their efficacy, and mitigate toxicity and side effects in the face of the climate change
crisis. Here are some noteworthy interventions that unfolded during the workshop:
1. Expanding Therapeutic Effects: Professor Anwar Rayan underscored the importance
of harnessing artificial intelligence and smart design to expand the therapeutic effects of
medicines.
2. Shifting the Paradigm: Professor Amiram Goldblum, a renowned researcher from the
Department of Pharmacy at the Hebrew University and a member of the Higher Academic
Council and Appointment Committee at Al-Qasemi Academy, discussed the significance
of transitioning from the traditional notion of "one disease - one biological target - one
drug" to the concept of "one disease - few biological targets - one drug."
3. Targeting Obesity Effectively: Dr Shaima Al-Atawneh, a faculty member in the
Department of Pharmacy at the Hebrew University, highlighted the effectiveness of
dual-action treatments and computerized mechanisms to expedite access to treatment
medicines for obesity-related issues.
4. Chemistry Library Selection: Professor Hanoch Senderowitz, a faculty member in the
Department of Chemistry at Bar-Ilan University, emphasized the importance of
examination and selection of chemistry libraries.
5. Reinforcement Learning for Peptidomimetic Macrocycle Discovery and Optimization:
Dr Amit Michaeli, the Scientific Director of Pepticom in Jerusalem, shared insights into
the successful utilization of reinforcement learning in discovering and improving
peptidomimetic drug candidates.
6. Cellular cross-talks for Cancer Treatment: Dr Mazid Falah, Director of the Research
Institute at the Holy Family Hospital in Nazareth, shed light on the potential of cellular
cross-talks as an effective tool/ a potential candidate for cancer treatment.